Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.

Anliker B, Choi JW, Lin ME, Gardell SE, Rivera RR, Kennedy G, Chun J.

Glia. 2013 Dec;61(12):2009-22. doi: 10.1002/glia.22572. Epub 2013 Sep 24.

2.

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.

Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, Noguchi K, Teo ST, Yung YC, Lu M, Kennedy G, Chun J.

Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):751-6. doi: 10.1073/pnas.1014154108. Epub 2010 Dec 21.

3.

Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation.

Spohr TC, Choi JW, Gardell SE, Herr DR, Rehen SK, Gomes FC, Chun J.

J Biol Chem. 2008 Mar 21;283(12):7470-9. doi: 10.1074/jbc.M707758200. Epub 2008 Jan 15. Erratum in: J Biol Chem. 2009 Dec 25;284(52):36720. de Sampaio E Spohr, Tânia Cristina [corrected to Spohr, Tânia Cristina].

4.

Emerging medicinal roles for lysophospholipid signaling.

Gardell SE, Dubin AE, Chun J.

Trends Mol Med. 2006 Feb;12(2):65-75. Epub 2006 Jan 10. Review.

PMID:
16406843
5.

Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.

Gardell LR, Vanderah TW, Gardell SE, Wang R, Ossipov MH, Lai J, Porreca F.

J Neurosci. 2003 Sep 10;23(23):8370-9.

Supplemental Content

Loading ...
Support Center